Literature DB >> 6248650

Noncontraceptive estrogens and myocardial infarction in young women.

L Rosenberg, D Slone, S Shapiro, D Kaufman, P D Stolley, O S Miettinen.   

Abstract

The effect of noncontraceptive estrogens on the risk of myocardial infarction (MI) in women aged 30 to 49 years was investigated in 477 women with first infarctions and in 1,832 hospital control subjects. There was little evidence of an effect: overall, the estimated relative risk of acute MI for women who had used noncontraceptive estrogens in the preceding month, after allowance for potential confounding factors, was 1.0 (95% confidence intervals, 0.6 to 1.7); the corresponding estimate for women who had discontinued use more than one month previously was 1.2 (0.8 to 1.8). There was also no apparent association in various subgroups, including women who smoked heavily and those who had no identified predisposition.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248650

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

Review 1.  Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.

Authors:  M K Goddard
Journal:  Br J Gen Pract       Date:  1992-03       Impact factor: 5.386

Review 2.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

Review 3.  Extraskeletal effects of estrogen and the prevention of atherosclerosis.

Authors:  T L Bush
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

4.  Smoking prevalence and associated risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  S J Stachenko; B A Reeder; E Lindsay; C Donovan; R Lessard; C Balram
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

5.  Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms.

Authors:  G Greenberg; S G Thompson; T W Meade
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

Review 6.  Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.

Authors:  Susan E Bromley; Corinne S de Vries; Dawn Thomas; Richard D T Farmer
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Cardiovascular disease and hormone replacement treatment: a pilot case-control study.

Authors:  S Adam; V Williams; M P Vessey
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-18

Review 8.  Postmenopausal osteoporosis.

Authors:  J C Stevenson; M I Whitehead
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

Review 9.  The risks and benefits of long-term estrogen replacement therapy.

Authors:  E L Barrett-Connor
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

10.  Postmenopausal oestrogen treatment and stroke: a prospective study.

Authors:  A Paganini-Hill; R K Ross; B E Henderson
Journal:  BMJ       Date:  1988 Aug 20-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.